Cover Image

Posterior Reversible Encephalopathy Syndrome

SARAVANAN s

Abstract


Introduction - Posterior reversible encephalopathy
syndrome (PRES) is a
clinicoradiologic entity occurring in varied
clinical setting and characterized by
headaches, confusion, visual disturbances,
seizures, and posterior transient
changes on neuroimaging. The radiological
features are often reported as demyelination
which confounds the diagnosis.
Observations - Of the 14 patients included
for the study, 13 (93 percent)
were females. The common symptom
being Headache in 13 (93 percent), Seizure
in 10 (71 percent), Visual disturbance
in 7 (50 percent), altered sensorium
in 7 (50 percent) and hypertension in
11 (78percent). On MRI the sites involved
were Occipital 13 (92 percent),
Parietal 9 (64 percent), frontal 4 (28 percent),
temporal 2 (14 percent), deep nuclei
2 (14 percent), cerebellum 1 (7 percent)
and brain stem 1 (7 percent). The
symptoms were reversible in 12 (86 percent)
patients, the remaining 2 (14 percent)
had complications of PRES with 1
(7 percent) having right occipital infarct
and 1 (7 percent)
right parietal hemorrhagic transformation.
Discussion -Acute rise in blood pressure is
one of the factors in the pathogenesis of
PRES, degree of raise in blood pressure
doesnt correlate with the clinical severity or
radiological manifestations. Pathophysiology
of PRES remains controversial with
two main hypotheses contradicting each
other. One being impaired cerebral autoregulation
leading to increased cerebral
blood flow (CBF) as noticed in severe hypertension,
whereas the other postulate is
endothelial dysfunction with cerebral hypoperfusion
as in cases with normal blood
pressure or on cytotoxic therapy. The common
final outcome in both is alteration in
cerebral perfusion with blood brain barrier
dysfunction causing vasogenic cerebral
edema. The common etiology of PRES in
this study was eclampsia, autoimmune disease,
renal disease and other causes.
Conclusion - PRES can manifest with
atypical features like normal blood pressure,
presence of MRI evidence of infarct
or hemorrhage. Clinical suspicion in appropriate
setting will lead to early diagnosis
and appropriate therapeutic intervention.
Reversibility of

the clinical and radiological abnormalities is
contingent on ealy treatment. On the contrary
when unrecognized, conversion to irreversible
cytotoxic edema may occur.


Full Text:

PDF

References


Alexander M. McKinney, James Short

et al., Posterior Reversible Encephalopathy

Syndrome: Incidence of

Atypical Regions of Involvement and

Imaging Findings: AJR 2007; 189:904

–912. DOI:10.2214/AJR.07.2024

Hinchey J, Chaves C, Appignani B,

et al. A reversible posterior leukoencephalopathy

syndrome. N Engl J Med

; 334:494–500

Schwartz RB, Jones KM, Kalina P,

et al. Hypertensive encephalopathy:

findings on CT, MR imaging and

SPECT imaging in 14 cases. AJR 1992;

:379–383.

Schwartz RB, Bravo SM, Klufas RA, et al.

Cyclosporine neurotoxicity and its relationship

to hypertensive encephalopathy: CT and MR

findings in 16 cases. AJR 1995; 165:627–631

Schwartz RB, Feske SK, Polak JF, et al.

Preeclampsia–eclampsia: clinical and neuroradiographic

correlates and insights into the

athogenesis of hypertensive encephalopathy.

Radiology 2000; 217:371–376

Truwit CL, Denaro CP, Lake JR, et al. MR

imaging of reversible cyclosporin A-induced

neurotoxicity. Am J Neuroradiol 1991; 12:651

–659

Covarrubias DJ, Luetmer PH, Campeau

NG. Posterior reversible encephalopathy syndrome:

prognostic utility of quantitative diffusion-

- weighted MR images. Am J Neuroradiol

; 23:1038–1048

Casey SO, Sampaio RC, Michel E, et al.

Posterior reversible encephalopathy syndrome:

utility of fluid-attenuated inversion recovery

MR imaging in the detection of cortical and subcortical

lesions. Am J Neuroradiol 2000; 21:1199–1206

Jarosz JM, Howlett DC, Cox TC, et al. Cyclosporine-

related reversible posterior leukoencephalopathy:

MRI. Neuroradiology

; 39:711–715

Schwartz RB, Mulkern RV, Gudbjartsson

H, et al. Diffusion-weighted MR imaging in hypertensive

encephalopathy: clues to pathogenesis.

Am J Neuroradiol 1998; 19:859–862

Dillon WP, Rowley H. The reversible posterior

cerebral edema syndrome. Am J Neuroradiol

;19:591

Johansson B. The blood–brain barrier and

cerebral blood flow in acute hypertension.

Acta Med Scand Suppl 1983; 678:107–112

Tamaki K, Sadoshima S, Baumbach

GL, et al. Evidence that disruption

of the blood–brain barrier precedes reduction

in cerebral blood flow in hypertensive

encephalopathy. Hypertension

; 6[2 Pt 2]:I-75–I-81

MacKenzie ET, Strandgaard S,

Graham DI, et al. Effects of acutely induced

hypertension in cats on pial arteriolar

caliber, local cerebral blood flow,

and the blood–brain barrier. Circ Res

; 39:33–41

Trommer BL, Homer D, Mikhael

MA. Cerebral vasospasm and eclampsia.

Stroke 1988; 19:326–329

Ito T, Sakai T, Inagawa S, et al. MR

angiography of cerebral vasospasm in

preeclampsia. Am J Neuroradiol 1995;

:1344–1346

H. Ay, F. S. Buonanno, P. W.

Schaefer, et al, Utility of diffusionweighted

MRI Posterior leukoencephalopathy

without severe hypertension

: Neurology 1998;51;1369:

DOI 10.1212/WNL.51.5.1369

Belogolovkin V, Levine SR, Fields

MC, Stone JL (2006) Postpartum

eclampsia complicated by reversible

cerebral herniation. Obstet Gynecol

: 442–445

Lamy C, Mas JL (2001) [Reversible

posterior leukoencephalopathy. A new

syndrome or a new name for an old

syndrome?]. Presse Med 30: 915–920

S. Legriel, F. Pico, and E. Azoulay;

Understanding Posterior Reversible

Encephalopathy Syndrome;

Kazuma Nakagawa, Farzaneh A. Sorond,,

Allan H. Ropper.” Ultra-Early Magnetic

Resonance Imaging Findings of

Eclampsia “ Arch Neurol. 2008;65(7):974-

doi:10.1001/archneur.65.7.974.

Sakaharova AV. Regional characteristics

of the noradrenergic and cholinergic

innervation of the vessels of the brain

surface. Bull Eksp Biol Med 1980; 89:141-

Bartynski WS, Boardman JF (2007)

Distinct imaging patterns and lesion distribution

in posterior reversible encephalopathy

syndrome. AJNR Am J Neuroradiol 28:

–1327

Steinborn M, Leiz S, Rudisser K, Griebel

M, Harder T, Hahn H. CT and MRI in

haemolytic uraemic syndrome with central

nervous system involvement: distribution

of lesions and prognostic value of imaging

findings. Pediatr Radiol 2004; 34:805-810.

Wijdicks EF (2001) Neurotoxicity of

immunosuppressive drugs. Liver Transpl

: 937–942

Wang X, Lo EH (2003) Triggers and

mediators of hemorrhagic transformation

in cerebral ischemia. Mol Neurobiol 28:

–244

Szabo C (2005) Mechanisms of cell

necrosis. Crit Care Med 33 (12 Suppl):

S530–534

Allport JR, Ding H, Collins T, Gerritsen

ME, Luscinskas FW (1997) Endothelialdependent

mechanisms regulate leukocyte

transmigration: a process involving the

proteasome and disruption of the vascular

endothelial-cadherin complex at endothelial

cell-to-cell junctions. J Exp Med 186:

–527

Sweany JM, Bartynski WS, Boardman

JF. “Recurrent” posterior reversible

encephalopathy syndrome: report of 3

cases—PRES can strike twice! J Comput

Assist Tomogr 2007;31:148–56

Sibai BM, Sarinoglu C, Mercer BM.

Eclampsia. VII. Pregnancy outcome after

eclampsia and long-term prognosis.

Am J Obstet Gynecol 1992;166(6 Pt 1):

–61, discussion 1761–63..


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University